Archer has signed an agreement with Hylid Diagnostics to develop an at-home testing device for chronic kidney disease as part of the Biochip project. • Archer and Hylid will combine their respective specialist blood sensing technologies to accelerate development and create a prototype system. • Hylid specialise in medical devices for the at-home testing of blood samples as well as having a team of advisors to aid in the entry of regulatory processes and the setup of clinical trials. • Archer and Hylid are now creating a detailed work plan for the next few months, including the first stage of the project which is to produce stand-alone hemolysis sensors that when used with Archer’s Biochip will meet potassium measurement accuracy requirements.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)